Baylor College of Medicine's Arthur Beaudet says he is seeing how genomic testing and sequencing is beginning to have an impact on how physicians approach treating rare disorders.

Beaudet, who has been treating children with rare disorders for 40 years, told MedScape at the recent Future of Genomic Medicine Conference that genetic testing began having an impact on his field through newborn screening. has posted the interview on its site.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.